Exagen Debt-to-Equity Ratio Growth & History (XGN)

Exagen's debt-to-equity ratio was 1.59 for fiscal 2025.

View full Exagen company overview

Exagen annual debt-to-equity ratio history

Exagen annual debt-to-equity ratio

Fiscal yearPeriod endedDebt-to-equity ratioChangeGrowth
20252025-12-311.59−0.86−35.26%
20242024-12-312.451.39+130.81%
20232023-12-311.060.21+24.97%
20222022-12-310.850.51+149.11%
20212021-12-310.34−0.32−48.23%
20202020-12-310.660.18+37.09%
20192019-12-310.48

Exagen debt-to-equity ratio trends

Over the last five fiscal years, Exagen's debt-to-equity ratio increased from 0.66 to 1.59, a change of 0.93. The latest reported quarter, Q2 2026, shows 2.26.

About the metric

What the debt-to-equity ratio means

The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.

Calculation and source

How debt-to-equity is calculated

TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Exagen source filings ↗

Community posts

It’s quiet here.

No posts about XGN yet. Start the conversation.

Write the first post